Wrap Technologies received a Schedule 13G from Iroquois Capital Management, Richard Abbe and Kimberly Page reporting a significant passive stake. Collectively, the reporting persons beneficially owned 4,425,830 shares of common stock, or 7.6% of the company’s outstanding shares as of February 3, 2026.
The position includes common stock plus shares issuable from Series A and Series B convertible preferred stock, warrants and pre-funded warrants, all subject to 4.99% and 9.99% beneficial ownership blockers that limit how much can be converted or exercised at any time. The filers certify the holdings are not for the purpose of changing or influencing control of the company.
Positive
None.
Negative
None.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
WRAP TECHNOLOGIES
(Name of Issuer)
Common Stock, $0.0001 par value
(Title of Class of Securities)
98212N107
(CUSIP Number)
02/03/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP No.
98212N107
1
Names of Reporting Persons
Iroquois Capital Management, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
3,597,026.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
3,597,026.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
3,597,026.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.2 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: Includes (i) 294,045 shares of Common Stock, (ii) 1,410,344 shares of Common Stock issuable upon conversion of 2,045 shares of the Company's Series A Convertible Preferred Stock (subject to a 4.99% Beneficial Ownership Blocker), (iii) 825,000 shares of Common Stock issuable upon conversion of 1237.5 shares of the Company's Series B Convertible Preferred Stock (subject to a 4.99% Beneficial Ownership Blocker), (iv) 3,643,966 shares of Common Stock issuable upon exercise of certain Warrants (subject to a 4.99% Beneficial Ownership Blocker), (v) 375,000 shares of Common Stock issuable upon exercise of certain Pre-Funded Warrants (subject to a 9.99% Beneficial Ownership Blocker), and (vi) 375,000 shares of Common Stock issuable upon exercise of certain Warrants (subject to a 9.99% Beneficial Ownership Blocker). As more fully described in Item 4, the Preferred Shares (as defined in Item 4) and certain Warrants are subject to a 4.99% Beneficial Ownership Blocker and the Pre-Funded Warrants and certain Warrants are subject to a 9.99% Beneficial Ownership Blocker, and the percentage set forth in row (11) gives effect to such Beneficial Ownership Blockers (as defined in Item 4). The shares reported in rows (6), (8) and (9) show the number of shares of Common Stock issuable upon conversion and/or exercise of such reported securities, giving effect to the Beneficial Ownership Blockers.
SCHEDULE 13G
CUSIP No.
98212N107
1
Names of Reporting Persons
Richard Abbe
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
3,690,824.00
6
Shared Voting Power
3,597,026.00
7
Sole Dispositive Power
3,690,824.00
8
Shared Dispositive Power
3,597,026.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,425,830.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.6 %
12
Type of Reporting Person (See Instructions)
HC, IN
Comment for Type of Reporting Person: Includes (i) 706,174 shares of Common Stock, (ii) 1,610,344 shares of Common Stock issuable upon conversion of 2,335 shares of the Company's Series A Convertible Preferred Stock (subject to a 4.99% Beneficial Ownership Blocker), (iii) 1,233,333 shares of Common Stock issuable upon conversion of 1,850 shares of the Company's Series B Convertible Preferred Stock (subject to a 4.99% Beneficial Ownership Blocker), (iv) 4,854,540 shares of Common Stock issuable upon exercise of certain Warrants (subject to a 4.99% Beneficial Ownership Blocker), (v) 800,000 shares of Common Stock issuable upon exercise of certain Pre-Funded Warrants (subject to a 9.99% Beneficial Ownership Blocker), and (vi) 800,000 shares of Common Stock issuable upon exercise of certain Warrants (subject to a 9.99% Beneficial Ownership Blocker). As more fully described in Item 4, the Preferred Shares (as defined in Item 4) and certain Warrants are subject to a 4.99% Beneficial Ownership Blocker and the Pre-Funded Warrants and certain Warrants are subject to a 9.99% Beneficial Ownership Blocker, and the percentage set forth in row (11) gives effect to such Beneficial Ownership Blockers (as defined in Item 4). The shares reported in rows (5), (6), (7), (8) and (9) show the number of shares of Common Stock issuable upon conversion and/or exercise of such reported securities, giving effect to the Beneficial Ownership Blockers.
SCHEDULE 13G
CUSIP No.
98212N107
1
Names of Reporting Persons
Kimberly Page
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
3,597,026.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
3,597,026.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
3,597,026.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.2 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: Includes (i) 294,045 shares of Common Stock, (ii) 1,410,344 shares of Common Stock issuable upon conversion of 2,045 shares of the Company's Series A Convertible Preferred Stock (subject to a 4.99% Beneficial Ownership Blocker), (iii) 825,000 shares of Common Stock issuable upon conversion of 1237.5 shares of the Company's Series B Convertible Preferred Stock (subject to a 4.99% Beneficial Ownership Blocker), (iv) 3,643,966 shares of Common Stock issuable upon exercise of certain Warrants (subject to a 4.99% Beneficial Ownership Blocker), (v) 375,000 shares of Common Stock issuable upon exercise of certain Pre-Funded Warrants (subject to a 9.99% Beneficial Ownership Blocker), and (vi) 375,000 shares of Common Stock issuable upon exercise of certain Warrants (subject to a 9.99% Beneficial Ownership Blocker). As more fully described in Item 4, the Preferred Shares (as defined in Item 4) and certain Warrants are subject to a 4.99% Beneficial Ownership Blocker and the Pre-Funded Warrants and certain Warrants are subject to a 9.99% Beneficial Ownership Blocker, and the percentage set forth in row (11) gives effect to such Beneficial Ownership Blockers (as defined in Item 4). The shares reported in rows (6), (8) and (9) show the number of shares of Common Stock issuable upon conversion and/or exercise of such reported securities, giving effect to the Beneficial Ownership Blockers.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
WRAP TECHNOLOGIES
(b)
Address of issuer's principal executive offices:
3480 Main Hwy, Suite 202, Miami, Florida 33133
Item 2.
(a)
Name of person filing:
This statement is being filed by (i) Iroquois Capital Management LLC, a Delaware limited liability company ("Iroquois"), (ii) Richard Abbe, and (iii) Kimberly Page ("Mr. Abbe" and "Ms. Page," together with Iroquois, the "Reporting Persons").
Mr. Abbe shares authority and responsibility for the investments made on behalf of Iroquois Master Fund Ltd. ("IMF") with Ms. Kimberly Page, each of whom is a director of IMF. As such, Mr. Abbe and Ms. Page may each be deemed to be the beneficial owner of all shares of Common Stock held by IMF. Iroquois Capital is the investment advisor for IMF and Mr. Abbe is the President of Iroquois Capital. Mr. Abbe has the sole authority and responsibility for the investments made on behalf of Iroquois Capital Investment Group LLC ("ICIG"). As such, Mr. Abbe may be deemed to be the beneficial owner of all shares of Common Stock held by Iroquois Master Fund and ICIG. The foregoing should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of shares of Common Stock owned by another Reporting Person. Each of the Reporting Persons disclaim beneficial ownership of these shares, except to the extent of its, his or her pecuniary interest in such shares, if any.
(b)
Address or principal business office or, if none, residence:
The principal business address for each of the Reporting Persons is 2 Overhill Road, Scarsdale, NY 10583.
(c)
Citizenship:
Iroquois Capital Management LLC is a Delaware limited liability company. Richard Abbe is an individual who is a citizen of the United States of America. Kimberly Page is an individual who is a citizen of the United States of America.
(d)
Title of class of securities:
Common Stock, $0.0001 par value
(e)
CUSIP No.:
98212N107
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Row 9 of each Reporting Person's cover page to this Schedule 13G sets forth the aggregate number of shares of securities of the Issuer beneficially owned by such Reporting Person as of the date of the event which requires filing of this statement and is incorporated herein by reference.
The Reporting Persons' ownership of the Issuer's securities includes: (i) 294,045 shares of Common Stock directly held by IMF and 412,129 shares of Common Stock directly held by ICIG, (ii) 1,410,344 shares of Common Stock issuable upon conversion of 2,045 shares of the Company's Series A Convertible Preferred Stock (subject to a 4.99% Beneficial Ownership Blocker (defined below)) held directly by IMF and 200,000 shares of Common Stock issuable upon conversion of 290 shares of the Company's Series A Convertible Preferred Stock (subject to a 4.99% Beneficial Ownership Blocker (defined below)) held directly by ICIG (collectively, the "Series A Preferred Shares"), (iii) 825,000 shares of Common Stock issuable upon conversion of 1,237.5 shares of the Company's Series B Convertible Preferred Stock (subject to a 4.99% Beneficial Ownership Blocker) held directly by IMF and 408,333 shares of Common Stock issuable upon conversion of 612.5 shares of the Company's Series B Convertible Preferred Stock (subject to a 4.99% Beneficial Ownership Blocker) held directly by ICIG (collectively, the "Series B Preferred Shares" and together with the Series A Preferred Shares, the "Preferred Shares"), (iv) 3,643,966 shares of Common Stock issuable upon exercise of certain Warrants (subject to a 4.99% Beneficial Ownership Blocker) held by IMF and 1,210,574 shares of Common Stock issuable upon exercise of certain Warrants (subject to a 4.99% Beneficial Ownership Blocker) held by ICIG, (v) 375,000 shares of Common Stock issuable upon exercise of certain Pre-Funded Warrants (subject to a 9.99% Beneficial Ownership Blocker (defined below)) held by IMF and 425,000 shares of Common Stock issuable upon exercise of certain Pre-Funded Warrants (subject to a 9.99% Beneficial Ownership Blocker) held by ICIG, and (vi) 375,000 shares of Common Stock issuable upon exercise of certain Warrants (subject to a 9.99% Beneficial Ownership Blocker) held by IMF and 425,000 shares of Common Stock issuable upon exercise of certain Warrants (subject to a 9.99% Beneficial Ownership Blocker) held by ICIG. The Preferred Shares and certain Warrants are subject to the 4.99% Beneficial Ownership Blocker and the Pre-Funded Warrants and certain Warrants are subject to the 9.99% Beneficial Ownership Blocker.
The Pre-Funded Warrants and certain Warrants contain provisions which precludes the exercise of such Pre-Funded Warrants and Warrants to the extent that, following exercise, the holder, together with its affiliates and other attribution parties, would own more than 9.99% of the Common Stock outstanding (the "9.99% Beneficial Ownership Blocker"). The Preferred Shares and certain of the Warrants contain provisions which precludes the exercise of such Warrants or the conversion of such Preferred Shares to the extent that, following exercise or conversion, as applicable, the holder, together with its affiliates and other attribution parties, would own more than 4.99% of the Common Stock outstanding (the "4.99% Beneficial Ownership Blocker", and together with the 9.99% Beneficial Ownership Blocker, the "Beneficial Ownership Blockers"). The Reporting Persons are currently prohibited from exercising certain Warrants or converting the Preferred Shares to the extent that such exercise or conversion, as applicable, would result in beneficial ownership of more than 2,119,206 shares of Common Stock due to the 4.99% Beneficial Ownership Blocker. The Reporting Persons are also currently prohibited from exercising the Pre-Funded Warrants and certain of the Pre-Funded Warrants to the extent that such exercise would result in beneficial ownership of more than 9.99% of the Common Stock outstanding. The shares of Common Stock listed as beneficially owned in Rows 5, 6, 7, 8 and 9 of the cover page for each Reporting Person and the percentage set forth in Row 11 of the cover page for each Reporting Person give effect to the Beneficial Ownership Blockers. Consequently, as of the date of the event which requires the filing of this statement, the Reporting Persons were not able to exercise all of the Warrants or convert all of the Preferred Shares due to the Beneficial Ownership Blockers.
(b)
Percent of class:
Row 11 of each Reporting Person's cover page to this Schedule 13G sets forth the percentages of the securities of the Issuer beneficially owned by such Reporting Person as of the date of the event which requires filing of this statement and is incorporated herein by reference. Due to the Beneficial Ownership Blockers, the collective beneficial ownership percentage of the Reporting Persons was 7.6% as of the date of the event which requires filing of this statement. Such percentage is based upon (i) 54,501,638 shares of the Issuer's Common Stock issued and outstanding as of February 6, 2026 as reported in the Issuer's Registration Statement on Form S-3 filed with the Securities and Exchange Commission ("SEC") on February 9, 2026 and (ii) shares of Common Stock issuable upon the conversion of the Preferred Shares and shares of Common Stock issuable upon the exercise of the Warrants and Pre-Funded Warrants after giving effect to the Beneficial Ownership Blockers.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(ii) Shared power to vote or to direct the vote:
The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(iii) Sole power to dispose or to direct the disposition of:
The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(iv) Shared power to dispose or to direct the disposition of:
The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Iroquois Capital Management, LLC
Signature:
/s/ Richard Abbe
Name/Title:
Richard Abbe, President
Date:
02/11/2026
Richard Abbe
Signature:
/s/ Richard Abbe
Name/Title:
Richard Abbe
Date:
02/11/2026
Kimberly Page
Signature:
/s/ Kimberly Page
Name/Title:
Kimberly Page
Date:
02/11/2026
Exhibit Information
Exhibit 1 Joint Filing Agreement as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
What stake in WRAP does Iroquois Capital report on this Schedule 13G?
Iroquois Capital and associated individuals report beneficial ownership of 4,425,830 shares of Wrap Technologies common stock, representing 7.6% of outstanding shares, based on 54,501,638 shares outstanding as of February 6, 2026.
Who are the reporting persons on the WRAP Schedule 13G filing?
The Schedule 13G is filed jointly by Iroquois Capital Management LLC, Richard Abbe, and Kimberly Page. Abbe and Page are directors of Iroquois Master Fund Ltd. and may be deemed beneficial owners of shares held by related investment entities.
How is the 7.6% WRAP ownership stake by Iroquois Capital calculated?
The 7.6% figure is based on 54,501,638 Wrap Technologies shares outstanding as of February 6, 2026, plus shares issuable from preferred stock, warrants and pre-funded warrants after applying the 4.99% and 9.99% beneficial ownership blockers.
What types of WRAP securities does Iroquois Capital beneficially own?
Holdings include common stock, Series A and Series B convertible preferred shares, warrants, and pre-funded warrants. The filing details millions of shares potentially issuable upon conversion or exercise, limited by specified beneficial ownership caps.
What are the 4.99% and 9.99% beneficial ownership blockers in WRAP’s securities?
The filing explains that certain preferred shares and warrants cannot be converted or exercised if doing so would push ownership above 4.99%, while pre-funded warrants and other warrants are capped at 9.99% of Wrap Technologies’ outstanding common stock.
Does Iroquois Capital seek control of Wrap Technologies with this 13G stake?
The reporting persons certify the securities were not acquired and are not held for the purpose of changing or influencing control of Wrap Technologies, consistent with a passive investment reported on Schedule 13G.
How much WRAP stock is outstanding according to the Schedule 13G?
The Schedule 13G states that Wrap Technologies had 54,501,638 shares of common stock issued and outstanding as of February 6, 2026, as reported in the company’s Registration Statement on Form S-3.
